US Stock MarketDetailed Quotes

VRDN Viridian Therapeutics

Watchlist
  • 17.850
  • -0.140-0.78%
Close Dec 13 16:00 ET
  • 20.000
  • +2.150+12.04%
Post 20:01 ET
1.41BMarket Cap-4.13P/E (TTM)

Viridian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-73.68%-67.71M
-1.87%-46.06M
27.03%-45.22M
-96.26%-184.17M
-11.63%-38M
-88.62%-38.98M
-149.99%-45.21M
-194.52%-61.97M
-71.92%-93.84M
-105.88%-34.04M
Net income from continuing operations
-60.91%-76.69M
-18.03%-64.99M
28.77%-48.54M
-83.05%-237.73M
-46.03%-66.86M
-64.88%-47.66M
-86.71%-55.06M
-165.25%-68.15M
-63.54%-129.87M
-58.17%-45.79M
Operating gains losses
----
----
----
--182K
--1K
----
----
----
----
----
Depreciation and amortization
-3.70%130K
7.58%142K
38.10%145K
104.71%522K
56.25%150K
117.74%135K
131.58%132K
162.50%105K
112.50%255K
200.00%96K
Other non cash items
-93.25%93K
-93.90%306K
12.63%107K
2,401.14%6.6M
128.57%112K
1,047.50%1.38M
10,356.25%5.02M
102.13%95K
-96.47%264K
-99.36%49K
Change In working capital
172.69%2.97M
337.02%11.13M
20.84%-4.96M
-159.05%-9.43M
-22.61%5.62M
-239.88%-4.08M
-176.28%-4.7M
-1,597.29%-6.26M
825.87%15.96M
657.52%7.26M
-Change in receivables
---14K
292.31%102K
--0
--0
--0
--0
115.12%26K
63.38%-26K
177.38%349K
960.71%297K
-Change in prepaid assets
-454.43%-4M
188.79%3.13M
-113.66%-4.47M
36.90%-2.11M
432.22%2.38M
202.36%1.13M
-351.67%-3.52M
-182.97%-2.09M
-123.20%-3.34M
-191.81%-717K
-Change in payables and accrued expense
237.23%7.05M
807.82%7.97M
89.88%-412K
-136.54%-7.03M
-57.34%3.31M
-235.31%-5.14M
-115.68%-1.13M
-892.02%-4.07M
533.94%19.24M
3,422.27%7.75M
-Change in other working capital
0.00%-72K
0.00%-72K
0.00%-72K
0.00%-288K
0.00%-72K
0.00%-72K
0.00%-72K
0.00%-72K
-145.28%-288K
-1.41%-72K
Cash from discontinued investing activities
Operating cash flow
-73.68%-67.71M
-1.87%-46.06M
27.03%-45.22M
-96.26%-184.17M
-11.63%-38M
-88.62%-38.98M
-149.99%-45.21M
-194.52%-61.97M
-71.92%-93.84M
-105.88%-34.04M
Investing cash flow
Cash flow from continuing investing activities
-276.24%-84.67M
52.23%61.98M
-975.93%-143.05M
18.13%-94.25M
6.03%-169.71M
12.64%48.04M
191.58%40.71M
-250.01%-13.3M
-54.96%-115.13M
-125.16%-180.6M
Net PPE purchase and sale
27.48%-293K
68.58%-104K
--0
-12.67%-898K
79.22%-48K
-325.26%-404K
-13.36%-331K
35.75%-115K
-207.72%-797K
-181.71%-231K
Net investment purchase and sale
-274.16%-84.37M
51.25%62.08M
-985.32%-143.05M
18.35%-93.35M
5.94%-169.66M
13.33%48.45M
187.93%41.04M
-245.76%-13.18M
-54.43%-114.33M
-125.10%-180.37M
Cash from discontinued investing activities
Investing cash flow
-276.24%-84.67M
52.23%61.98M
-975.93%-143.05M
18.13%-94.25M
6.03%-169.71M
12.64%48.04M
191.58%40.71M
-250.01%-13.3M
-54.96%-115.13M
-125.16%-180.6M
Financing cash flow
Cash flow from continuing financing activities
1,485.19%245.02M
-96.48%108K
2,058.48%177.08M
-29.97%225.67M
664.75%198.94M
-94.69%15.46M
-32.69%3.07M
1,011.65%8.2M
157.23%322.24M
15,202.35%26.01M
Net issuance payments of debt
----
----
----
200.00%15M
--0
----
----
----
--5M
--446K
Net common stock issuance
--233.75M
--0
--186.27M
-57.15%125.07M
398.56%125.07M
--0
--0
--0
155.49%291.87M
2,398.61%25.09M
Net preferred stock issuance
----
----
----
73.16%76.19M
--76.19M
----
----
----
159.43%44M
--0
Proceeds from stock option exercised by employees
46.86%1.43M
-93.16%210K
-85.45%1.19M
459.90%21.72M
411.38%9.48M
-24.38%971K
76,600.00%3.07M
1,011.65%8.2M
65.04%3.88M
73.43%1.85M
Net other financing activities
---15.15M
---102K
---10.38M
45.29%-12.32M
-760.13%-11.8M
----
----
----
-171.93%-22.51M
27.90%-1.37M
Cash from discontinued financing activities
Financing cash flow
1,485.19%245.02M
-96.48%108K
2,058.48%177.08M
-29.97%225.67M
664.75%198.94M
-94.69%15.46M
-32.69%3.07M
1,011.65%8.2M
157.23%322.24M
15,202.35%26.01M
Net cash flow
Beginning cash position
23.64%107.67M
3.53%91.64M
-33.91%102.83M
267.81%155.58M
-67.58%111.6M
178.28%87.08M
186.85%88.52M
267.81%155.58M
-7.84%42.3M
147.86%344.21M
Current changes in cash
277.93%92.65M
1,218.35%16.03M
83.32%-11.19M
-146.57%-52.75M
95.35%-8.77M
-92.17%24.52M
-429.43%-1.43M
-486.17%-67.06M
3,248.42%113.28M
-95.32%-188.63M
End cash Position
79.50%200.32M
23.64%107.67M
3.53%91.64M
-33.91%102.83M
-33.91%102.83M
-67.58%111.6M
178.28%87.08M
186.85%88.52M
267.81%155.58M
267.81%155.58M
Free cash flow
-72.64%-68M
-1.35%-46.16M
27.16%-45.22M
-95.56%-185.07M
-11.01%-38.05M
-89.70%-39.39M
-147.82%-45.55M
-192.58%-62.09M
-72.32%-94.64M
-106.23%-34.27M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -73.68%-67.71M-1.87%-46.06M27.03%-45.22M-96.26%-184.17M-11.63%-38M-88.62%-38.98M-149.99%-45.21M-194.52%-61.97M-71.92%-93.84M-105.88%-34.04M
Net income from continuing operations -60.91%-76.69M-18.03%-64.99M28.77%-48.54M-83.05%-237.73M-46.03%-66.86M-64.88%-47.66M-86.71%-55.06M-165.25%-68.15M-63.54%-129.87M-58.17%-45.79M
Operating gains losses --------------182K--1K--------------------
Depreciation and amortization -3.70%130K7.58%142K38.10%145K104.71%522K56.25%150K117.74%135K131.58%132K162.50%105K112.50%255K200.00%96K
Other non cash items -93.25%93K-93.90%306K12.63%107K2,401.14%6.6M128.57%112K1,047.50%1.38M10,356.25%5.02M102.13%95K-96.47%264K-99.36%49K
Change In working capital 172.69%2.97M337.02%11.13M20.84%-4.96M-159.05%-9.43M-22.61%5.62M-239.88%-4.08M-176.28%-4.7M-1,597.29%-6.26M825.87%15.96M657.52%7.26M
-Change in receivables ---14K292.31%102K--0--0--0--0115.12%26K63.38%-26K177.38%349K960.71%297K
-Change in prepaid assets -454.43%-4M188.79%3.13M-113.66%-4.47M36.90%-2.11M432.22%2.38M202.36%1.13M-351.67%-3.52M-182.97%-2.09M-123.20%-3.34M-191.81%-717K
-Change in payables and accrued expense 237.23%7.05M807.82%7.97M89.88%-412K-136.54%-7.03M-57.34%3.31M-235.31%-5.14M-115.68%-1.13M-892.02%-4.07M533.94%19.24M3,422.27%7.75M
-Change in other working capital 0.00%-72K0.00%-72K0.00%-72K0.00%-288K0.00%-72K0.00%-72K0.00%-72K0.00%-72K-145.28%-288K-1.41%-72K
Cash from discontinued investing activities
Operating cash flow -73.68%-67.71M-1.87%-46.06M27.03%-45.22M-96.26%-184.17M-11.63%-38M-88.62%-38.98M-149.99%-45.21M-194.52%-61.97M-71.92%-93.84M-105.88%-34.04M
Investing cash flow
Cash flow from continuing investing activities -276.24%-84.67M52.23%61.98M-975.93%-143.05M18.13%-94.25M6.03%-169.71M12.64%48.04M191.58%40.71M-250.01%-13.3M-54.96%-115.13M-125.16%-180.6M
Net PPE purchase and sale 27.48%-293K68.58%-104K--0-12.67%-898K79.22%-48K-325.26%-404K-13.36%-331K35.75%-115K-207.72%-797K-181.71%-231K
Net investment purchase and sale -274.16%-84.37M51.25%62.08M-985.32%-143.05M18.35%-93.35M5.94%-169.66M13.33%48.45M187.93%41.04M-245.76%-13.18M-54.43%-114.33M-125.10%-180.37M
Cash from discontinued investing activities
Investing cash flow -276.24%-84.67M52.23%61.98M-975.93%-143.05M18.13%-94.25M6.03%-169.71M12.64%48.04M191.58%40.71M-250.01%-13.3M-54.96%-115.13M-125.16%-180.6M
Financing cash flow
Cash flow from continuing financing activities 1,485.19%245.02M-96.48%108K2,058.48%177.08M-29.97%225.67M664.75%198.94M-94.69%15.46M-32.69%3.07M1,011.65%8.2M157.23%322.24M15,202.35%26.01M
Net issuance payments of debt ------------200.00%15M--0--------------5M--446K
Net common stock issuance --233.75M--0--186.27M-57.15%125.07M398.56%125.07M--0--0--0155.49%291.87M2,398.61%25.09M
Net preferred stock issuance ------------73.16%76.19M--76.19M------------159.43%44M--0
Proceeds from stock option exercised by employees 46.86%1.43M-93.16%210K-85.45%1.19M459.90%21.72M411.38%9.48M-24.38%971K76,600.00%3.07M1,011.65%8.2M65.04%3.88M73.43%1.85M
Net other financing activities ---15.15M---102K---10.38M45.29%-12.32M-760.13%-11.8M-------------171.93%-22.51M27.90%-1.37M
Cash from discontinued financing activities
Financing cash flow 1,485.19%245.02M-96.48%108K2,058.48%177.08M-29.97%225.67M664.75%198.94M-94.69%15.46M-32.69%3.07M1,011.65%8.2M157.23%322.24M15,202.35%26.01M
Net cash flow
Beginning cash position 23.64%107.67M3.53%91.64M-33.91%102.83M267.81%155.58M-67.58%111.6M178.28%87.08M186.85%88.52M267.81%155.58M-7.84%42.3M147.86%344.21M
Current changes in cash 277.93%92.65M1,218.35%16.03M83.32%-11.19M-146.57%-52.75M95.35%-8.77M-92.17%24.52M-429.43%-1.43M-486.17%-67.06M3,248.42%113.28M-95.32%-188.63M
End cash Position 79.50%200.32M23.64%107.67M3.53%91.64M-33.91%102.83M-33.91%102.83M-67.58%111.6M178.28%87.08M186.85%88.52M267.81%155.58M267.81%155.58M
Free cash flow -72.64%-68M-1.35%-46.16M27.16%-45.22M-95.56%-185.07M-11.01%-38.05M-89.70%-39.39M-147.82%-45.55M-192.58%-62.09M-72.32%-94.64M-106.23%-34.27M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List